N. Thomson (Glasgow, United Kingdom), M. Walker (Vancouver, Canada)
Effect of roflumilast on inflammatory cell volume density in lungs of mice chronically exposed to cigarette smoke
P. A. Martorana, B. Lunghi, M. Lucatelli, R. Beume, G. Lungarella (Siena, Italy; Konstanz, Germany)
|   |
The mechanism of tianlong decoction (TLD) suppressing airway hyperreactivity (AHR) in asthma
Y. F. Luo, W. J. Li, J. Xu (Guangzhou, China)
| |
In vitro delivery of budesonide from 10 jet nebulisers using a child breathing pattern
E. Berg, R. Picard (Lund, Sweden)
| |
Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma
S. Y. Lee, S. J. Kim, S. C. Kim, J. H. Ann, M. S. Kim, S. S. Kim, S. S. Kwon, S. H. Park (Seoul, Republic Of Korea)
| |
The prophylactic effect of Nigella sativa on asthma disease
M. H. Boskabady, H. Javan, M. Sajadi, H. Rakhshandah (Mashhad, Islamic Republic Of Iran)
| |
Short term tolerance of hypertonic saline aerosol delivered intranasally
N. Tiffin, W. Ashley, C. Lisa, L. Mecimore (Midlothian, VA, United States Of America)
| |
Performance characteristics of a new nebulizer for heliox
N. Tiffin, R. Vohra, S. Nowack, L. Weinstein (Midlothian, VA, United States Of America)
| |
The regulatory role of SS320A (fudosteine) in the MUC5AC mucin synthesis
J. S. Song, C. M. Kang, M. B. Yoo, S. J. Kim, H. K. Yoon, H. S. Moon, S. H. Park (Seoul, Republic Of Korea)
| |
LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice
K. Fukuchi, T. Yasue, T. Kishi (Tochigi, Japan)
| |
In-depth characterization of in vivo LPS models
E. Benediktus, R. Goeggel, B. Jung (Biberach, Germany)
| |
Thermal spring water reduces the airway inflammation in patients with chronic bronchitis
T. Cappelletti, S. Della Patrona, F. Denti, M. Volpi, L. Allegra (Milan, Italy)
| |
Therapeutic effect of roflumilast on LPS- and OVA-induced goblet cell hyperplasia in rats
A. Weidenbach, C. Braun, M. D. Lehner, F. Schwoebel, R. Beume, J. Barsig (Konstanz, Germany)
| |
In vitro pharmacological profile of CHF 5407, a potent, long-acting and selective muscarinic M3 receptor antagonist
R. Patacchini, M. Bergamaschi, S. Harrison, P. Petrillo, P. M. Gigli, A. Janni, P. Geppetti, G. Villetti, G. Amari, A. Rizzi, M. Delcanale, M. Civelli (Parma, Florence, Baranzate di Bollate (Milano), Italy)
| |
In vivo potent and long-lasting bronchodilator activity of muscarinic M3 receptor antagonist CHF5407
G. Villetti, F. Bassani, M. Bergamaschi, P. T. Bolzoni, G. Amari, M. Delcanale, A. Rizzi, G. Rossoni, F. Berti, B. P. Imbimbo, R. Razzetti, R. Patacchini, M. Civelli (Parma, Milan, Italy)
| |
Characterization of the Toll-IL-1 pathway gene profile in an in-vitro model of chronic airway inflammation
Y. Zhang, L. O. Cardell (Malmo, Sweden)
| |
Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation
C. M. Starling, C. M. Prado, E. A. Leick-Maldonado, F. G. dos Reis, L. R. C. R. B. Aristóteles, M. A. Martins, I. F. L. C. Tibério (São Paulo, Brazil)
| |
Liver-X-receptor agonists, but not dexamethasone, inhibit leukotriene production from human white blood cells pretreated with GM-CSF and activated with fMLP
B. Jacobson, D. Bamford, M. Bowman (Cambridge, MA, United States Of America)
| |
Effects of neuraminidase on equine isolated bronchi
L. Calzetta, A. Sanduzzi, M. Cazzola, M. G. Matera (Naples, Rome, Italy)
| |
The histological effects of interleukin-10 on mouse lung inflammation after recombinant Sendai virus vector transduction
S. Qiu, U. Griesenbach, H. Gautrey, L. Somerton, P. Jeffery, E. Alton, J. Zhu (London, Cambridge, United Kingdom)
| |